aids situation in spains. benet garrabé1, g. verdejo muñoz2, l.j. garcia-fraile fraile3, a.c....

1
S. Benet Garrabé 1 , G. Verdejo Muñoz 2 , L.J. Garcia-Fraile Fraile 3 , A.C. Silva Klug 4 1 Hospital Universitari Germans Trias i Pujol, Badalona 2 Hospital Clínico Lozano Blesa, Zaragoza 3 Hospital U La Princesa, Madrid 4 Hospital Universitari de Bellvitge, Barcelona HIV/AIDS SITUATION IN SPAIN THE HIV/AIDS EPIDEMIC IN SPAIN DELAY ON HIV DIAGNOSIS NEW HIV INFECTIONS IN SPAIN (2015) 10 new cases per day 3.428 new HIV diagnosis in 2015 497 new AIDS diagnosis in 2015 140.700 people living with HIV 85.720 total AIDS diagnosis 85,9% 14,1% 36 years old GENDER HIV TRANSMISSION ORIGIN 53,6% 0% 25,4% 2,8% MSM Mother-to-child Heterosexual Injection drug use Spain Other countries 69,7% 30,3% 46,5% <200 CD4 27,1% 200-349 CD4 19,4% <350 CD4 Sevilla Mardrid Barcelona BCN Checkpoint Adhara Apoyo Positivo Community centers for early diagnosis of STD 54,5% of women 45,3% of men 38,4% of 54,4% of 60% of MSM Heterosexual Injection drug users < < < Heterosexual 63,1% of New HIV/AIDS diagnosis in Spain according to gender, age, mechanism of HIV transmission and origin. Despite MSM represent the higher volume of new HIV infections, they have a lower delayed HIV diagnosis ratio. In Spain, there are three community centers that together with healthcare centers promote early diagnosis of STD on MSM. CHANGES IN THE NATURAL HISTORY OF HIV In 2015, 46,5% of new HIV infected people presented a delayed HIV diagnosis. THE HIV TREATMENT CASCADE CLINICAL MANAGEMENT 100% 82% 76% 81% People living with HIV HIV diagnosed On cART Virally supressed 50% An estimated 50% people living with HIV in Spain are virally supressed. Aging Antiretroviral drug toxicity Coinfection HCV, HPV, syphilis Drug-drug interactions Comorbidities cardiovascular, bone, kidney, neurocognitive, neoplasia Early detection of anal cancer Anoscopy, anal-rectal cytology Multidisciplinary attention AIDS RELATED DISEASES 0 10 20 30 Extrapulmonary cryptococcosis HIV-related encephalopathy Bacterial pneumonia Progressive multifocal leukoencephalopathy Cytomegalovirus Cerebral toxoplasmosis No hodgkin lymphoma wasting syndrome Kaposi's sarcoma Esophageal candidiasis Tuberculosis P. jirovecii pneumonia % HIV/HCV COINFECTION MORTALITY CAUSES IN HIV INFECTED INDIVIDUALS A multidisciplinary attention is offered to HIV infected patients, with special care to other STD and anal cancer detection. P. jirovecii pneumonia is the most frequent AIDS related disease (27%), followed by tu- berculosis (21,4%) and esophageal candi- diasis (13,2%). 2000 2005 2010 2015 0 3 6 9 12 Rate per 100.000 population Gonorrhea Syphilis TRENDS IN SEXUALLY TRANSMITTED DISEASES The incidence of gonorrhea and syphilis in the HIV population has in- creased 4-fold over the last 10 years. The incidence of HIV/HCV coinfection has dropped significantly due to the appearance of new antiviral drugs and the reduction of injection drug users. 4X 497 7494 New HIV/AIDS cases 2015 1995 1981 Number of HIV/AIDS deaths 5857 2015 1995 1981 633 1,4/100.000 inhabitants 513 120 HAART Since 1997, with the begining of HAART there was a marked decline in the number of new HIV/AIDS diagnosis and the number of HIV/ AIDS related deaths. TDF/FTC + RAL or TAF/FTC + RAL TDF/FTC + DTG or TAF/FTC + DTG ABC/3TC + DTG TAF/FTC + EVG/COBI TDF/FTC + RPV TDF/FTC + DRV/r TDF/FTC + EVG/COBI Preferred combinations Alternatives The rate of new HIV diagnosis decreases over time among drug injection users and heterosexual trans- mission, but remains stable for MSM until 2014. EVOLUTION OF NEW HIV DIAGNOSIS ACCORDING TO THE MECHANISM OF TRANSMISSION 2009 2011 2013 2015 0 500 1000 1500 2000 Number of cases Drug injection users Heterosexual MSM Overall, AIDS associated diseases, non-AIDS-defining malingnancies and liver disease are the main causes of mortality in HIV infected individuals. (Alejos B. et al. Medicine (Baltimore); sep 2016). AIDS associated diseases Non-AIDS-defining malignancies Liver disease Non-AIDS infections Cardiovascular diseases Pulmonary diseases Drug abuse Suicide External causes Other (Vigilancia epidemiológica del VIH y SIDA en España. Ministerio de Sanidad, Asuntos Sociales e Igualdad, Junio 2016) (Vigilancia epidemiológica del VIH y SIDA en España. Ministerio de Sanidad, Asuntos Sociales e Igualdad, Junio 2016) (Vigilancia epidemiológica del VIH y SIDA en España. Ministerio de Sanidad, Asuntos Sociales e Igualdad, Junio 2016) (Gourlay A. et al. CID; June 2017)

Upload: others

Post on 26-Feb-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: AIDS situation in SpainS. Benet Garrabé1, G. Verdejo Muñoz2, L.J. Garcia-Fraile Fraile3, A.C. Silva Klug4 1Hospital Universitari Germans Trias i Pujol, Badalona 2Hospital Clínico

S. Benet Garrabé1, G. Verdejo Muñoz2, L.J. Garcia-Fraile Fraile3, A.C. Silva Klug4

1Hospital Universitari Germans Trias i Pujol, Badalona 2Hospital Clínico Lozano Blesa, Zaragoza 3Hospital U La Princesa, Madrid 4Hospital Universitari de Bellvitge, Barcelona

HIV/AIDS SITUATION IN SPAIN

THE HIV/AIDS EPIDEMIC IN SPAIN DELAY ON HIV DIAGNOSIS

NEW HIV INFECTIONS IN SPAIN (2015)

10 new cases per day3.428 new HIV diagnosis in 2015497 new AIDS diagnosis in 2015140.700 people living with HIV

85.720 total AIDS diagnosis

85,9%14,1%

36 years old

GENDER HIV TRANSMISSION

ORIGIN

53,6% 0%25,4% 2,8%

MSM Mother-to-childHeterosexualInjectiondrug use

Spain Other countries

69,7% 30,3%

46,5%

<200 CD427,1%

200-349 CD419,4%

<350 CD4

Sevilla

Mardrid

Barcelona BCN Checkpoint

Adhara

Apoyo Positivo

Community centers for early diagnosis of STD

54,5% ofwomen

45,3% ofmen

38,4%of

54,4%of

60% of

MSM HeterosexualInjection

drug users

< < <

Heterosexual

63,1%of

New HIV/AIDS diagnosis in Spain according to gender, age, mechanism of HIV transmission and origin.

Despite MSM represent the higher volume of new HIV infections, they have a lower delayed HIV diagnosis ratio. In Spain, there are three community centers that together with healthcare centers promote early diagnosis of STD on MSM.

CHANGES IN THE NATURAL HISTORY OF HIV

In 2015, 46,5% of new HIV infected people presented a delayed HIV diagnosis.

THE HIV TREATMENT CASCADE CLINICAL MANAGEMENT

100%

82%

76%

81%

People living with HIV

HIV diagnosed

On cART

Virally supressed 50%

An estimated 50% people living with HIV in Spain are virally supressed.

Aging

Antiretroviral drug toxicity

CoinfectionHCV, HPV, syphilis

Drug-druginteractions

Comorbiditiescardiovascular, bone, kidney,

neurocognitive, neoplasia

Early detection of anal cancer

Anoscopy,anal-rectal

cytology

Multidisciplinaryattention

AIDS RELATED DISEASES

0 10 20 30

Extrapulmonary cryptococcosis

HIV-related encephalopathy

Bacterial pneumonia

Progressive multifocal leukoencephalopathyCytomegalovirus

Cerebral toxoplasmosis

No hodgkin lymphoma

wasting syndrome

Kaposi's sarcoma

Esophageal candidiasis

Tuberculosis

P. jirovecii pneumonia

%

HIV/HCV COINFECTIONMORTALITY CAUSES IN HIV INFECTED INDIVIDUALS

A multidisciplinary attention is offered to HIV infected patients, with special care to other STD and anal cancer detection.

P. jirovecii pneumonia is the most frequent AIDS related disease (27%), followed by tu-berculosis (21,4%) and esophageal candi-diasis (13,2%).

2000

2005

2010

2015

0

3

6

9

12

Rat

e pe

r 100

.000

pop

ulat

ion

Gonorrhea

Syphilis

TRENDS IN SEXUALLY TRANSMITTED DISEASES

The incidence of gonorrhea and syphilis in the HIV population has in-creased 4-fold over the last 10 years.

The incidence of HIV/HCV coinfection has dropped significantly due to the appearance of new antiviral drugs and the reduction of injection drug users.

4X

497

7494

New HIV/AIDS cases

201519951981

Number of HIV/AIDS deaths

5857

201519951981

633

1,4/100.000 inhabitants513 120

HAART

Since 1997, with the begining of HAART there was a marked decline in the number of new HIV/AIDS diagnosis and the number of HIV/AIDS related deaths.

TDF/FTC + RAL or TAF/FTC + RAL

TDF/FTC + DTG or TAF/FTC + DTG

ABC/3TC + DTG

TAF/FTC + EVG/COBI

TDF/FTC + RPVTDF/FTC + DRV/r

TDF/FTC + EVG/COBI

Preferred combinationsAlternatives

The rate of new HIV diagnosis decreases over time among drug injection users and heterosexual trans-mission, but remains stable for MSM until 2014.

EVOLUTION OF NEW HIV DIAGNOSISACCORDING TO THE MECHANISM OF TRANSMISSION

2009

2011

2013

2015

0

500

1000

1500

2000

Num

ber o

f cas

es

Drug injection users

Heterosexual

MSM

Overall, AIDS associated diseases, non-AIDS-defining malingnancies and liver disease are the main causes of mortality in HIV infected individuals. (Alejos B. et al. Medicine (Baltimore); sep 2016).

AIDS associated diseasesNon-AIDS-defining malignanciesLiver diseaseNon-AIDS infectionsCardiovascular diseasesPulmonary diseasesDrug abuseSuicideExternal causesOther

(Vigilancia epidemiológica del VIH y SIDA en España. Ministerio de Sanidad, Asuntos Sociales e Igualdad, Junio 2016)

(Vigilancia epidemiológica del VIH y SIDA en España. Ministerio de Sanidad, Asuntos Sociales e Igualdad, Junio 2016)

(Vigilancia epidemiológica del VIH y SIDA en España. Ministerio de Sanidad, Asuntos Sociales e Igualdad, Junio 2016)

(Gourlay A. et al. CID; June 2017)